Aspirin's colon cancer prevention limited

Share this article:
Gene Mutation Influences Aspirin's Colon Cancer Benefit
Gene Mutation Influences Aspirin's Colon Cancer Benefit

(HealthDay News) -- Regular aspirin use is associated with a lower risk of developing colorectal cancer, but only cancers without mutations in the BRAF oncogene, according to a study published in the June 26 issue of the Journal of the American Medical Association.

Reiko Nishihara, Ph.D., from the Dana-Farber Cancer Institute in Boston, and colleagues analyzed data from 127,865 participants in two large studies to examine the association between aspirin intake and colorectal cancer risk based on the presence of tumor mutations in the BRAF oncogene.

The researchers found that there were 1,226 incident rectal and colon cancers during follow-up. After adjusting for various factors, regular aspirin use was associated with a lower risk of BRAF-wild-type cancer (hazard ratio [HR], 0.73) but not BRAF-mutated cancer (HR, 1.03). The association was unaffected by the status of tumor prostaglandin-endoperoxide synthase 2 expression or PIK3CA or KRAS mutation. Increasing the number of aspirin tablets per week lowered the risk of BRAF-wild-type cancer (HR, 0.43 for >14 tablets per week), while more tablets had no effect on the risk of BRAF-mutated cancer.

"Regular aspirin use was associated with lower risk of BRAF-wild-type colorectal cancer but not with BRAF-mutated cancer risk," Nishihara and colleagues conclude. "These findings suggest that BRAF-mutant colon tumor cells may be less sensitive to the effect of aspirin."

One author has been a consultant for several pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Chest radiation may be useful for combatting advanced lung cancers

Chest radiation may be useful for combatting advanced ...

The addition of chest radiation reduces recurrence rate and, improves survival when added to chemo in extensive stage small-cell lung cancer.

Market changes needed as patients take on greater care costs

Market changes needed as patients take on greater ...

As consumers take on more costs of care, access to data for informed decisions is deemed crucial.

For black men with prostate cancer, watchful waiting may be unwise

For black men with prostate cancer, watchful waiting ...

For men with early-stage prostate cancer, watching waiting is not always the best course of action, especially for black patients.